259P Relationship between initial tumor burden and the probability of pathological complete response within molecular subtypes of early breast cancer treated with neoadjuvant chemo... von Roussot, N., Constantin, G., Desmoulins, I., Kaderbhai, C., Hennequin, A., Ilie, S.M., Mayeur, D., Arnould, L., Bertaut, A., Eymard, J-C., Jouannaud, C., Savoye, A.M., Yazbek, G., Allouache, D., Delcambre, C., Hrab, I., Levy, C., Djezzer, C. Segura, Deblock, M., Ladoire, S.

Volltext

104P HELENA: Study of HER2-low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer von Cherifi, F., Da Silva, A., Johnson, A.C., Blanc Fournier, C., Broyelle, A., Abramovici, O., Morel, A., Bertho, M., Hrab, I., Allouache, D., Segura Djezzer, C., Levy, C., Boscher, C., Villemin, M., Rottier, P., Lequesne, J., Emile, G.

Volltext

255P Prognostic stratification capacity of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy von Roussot, N., Constantin, G., Desmoulins, I., Kaderbhai, C., Hennequin, A., Mayeur, D., Ilie, S.M., Arnould, L., Bertaut, A., Eymard, J-C., Jouannaud, C., Savoye, A.M., Yazbek, G., Allouache, D., Delcambre, C., Hrab, I., Levy, C., Djezzer, C. Segura, Deblock, M., Ladoire, S.

Volltext

117P Pretherapeutic neutrophil-lymphocyte ratio as prognostic and predictive factors in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors von Rottier, P., Da Silva, A., Levy, C., Allouache, D., Johnson, A.C., Hrab, I., Faveyrial, A., Gunzer, K., Segura Djezzer, C., Morel, A., Villemin, M., Boscher, C., Boismoreau, L., Cherifi, F., Lequesne, J., Emile, G.

Volltext

112P Correlation between HER2-negative status and risk of recurrence according to PAM50 score von Montagnon, L., Emile, G., Rouzier, R., Hequet, D., Levy, C., Morel, A., Djezzer, C. Segura, Hrab, I., Dubot, C., Johnson, A.C., Allouache, D., Rottier, P., Etancelin, P., Blanc-Fournier, C., Cherifi, F., Lequesne, J., Da Silva, A.

Volltext